At least two recent studies have found bariatric surgery more cost-effective, long term, than the pricey glucagon-like peptide 1 (GLP-1) receptor agonist obesity medications. Another recent study ...

As weight-loss medications like Ozempic exploded across the U.S. over the past four years, bariatric surgeons faced a bit of an existential crisis: Were their jobs about to become obsolete? For the ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that targets four gut hormones instead of the usual one to three. These next-gen ...

Amid the surge in GLP-1 weight-loss medications, some have questioned whether invasive procedures like lap band, gastric sleeve and bypass surgeries could wane in popularity. Carnie Wilson, of the ...

Bariatric surgery is more cost-effective and offers better long-term outcomes than GLP-1 RAs for obesity and metabolic comorbidities. GLP-1 RAs face challenges like high costs, limited insurance ...

Metabolic surgery was associated with lower all-cause mortality and a lower risk for major adverse cardiac events than GLP-1 receptor agonists (RAs), based on data from a new study of more than 3000 ...